TTC19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.449600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.704000E-01
Normal-vs-Stage2
7.037200E-01
Normal-vs-Stage3
4.219900E-02
Normal-vs-Stage4
4.360200E-02
Stage1-vs-Stage2
8.144800E-01
Stage1-vs-Stage3
1.343010E-01
Stage1-vs-Stage4
2.283000E-01
Stage2-vs-Stage3
1.116200E-01
Stage2-vs-Stage4
2.044600E-01
Stage3-vs-Stage4
5.511000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.452200E-01
Normal-vs-AfricanAmerican
9.713500E-02
Normal-vs-Asian
2.184000E-03
Caucasian-vs-AfricanAmerican
3.326200E-01
Caucasian-vs-Asian
2.226300E-02
AfricanAmerican-vs-Asian
1.790130E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.913200E-01
Normal-vs-Female
4.304200E-02
Male-vs-Female
4.875800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.217400E-01
Normal-vs-Age(41-60Yrs)
6.423600E-01
Normal-vs-Age(61-80Yrs)
8.743200E-01
Normal-vs-Age(81-100Yrs)
3.900200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.172200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.582200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.918800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.986200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.489800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.808800E-01
Normal-vs-Daily Drinker
4.130100E-02
Normal-vs-Weekly Drinker
1.918010E-02
Normal-vs-Occasional Drinker
6.770200E-01
Normal-vs-Social Drinker
8.937600E-01
Non Drinker-vs-Daily Drinker
8.948000E-01
Non Drinker-vs-Weekly Drinker
4.223800E-01
Non Drinker-vs-Occasional Drinker
1.621240E-01
Non Drinker-vs-Social Drinker
3.248000E-01
Daily Drinker-vs-Weekly Drinker
4.426800E-01
Daily Drinker-vs-Occasional Drinker
2.779000E-01
Daily Drinker-vs-Social Drinker
3.817400E-01
Weekly Drinker-vs-Occasional Drinker
6.901800E-02
Weekly Drinker-vs-Social Drinker
1.870950E-01
Occasional Drinker-vs-Social Drinker
9.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.796600E-01
Normal-vs-Grade 2
7.718400E-01
Normal-vs-Grade 3
2.670800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.295200E-01
Grade 1-vs-Grade 3
8.748100E-02
Grade 1-vs-Grade 4
2.796600E-01
Grade 2-vs-Grade 3
4.779200E-01
Grade 2-vs-Grade 4
7.718400E-01
Grade 3-vs-Grade 4
2.670800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.390200E-02
Normal-vs-NonDiabetic
4.445900E-02
Diabetic-vs-NonDiabetic
3.896300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.377800E-01
Normal-vs-NoPancreatitis
6.763900E-03
Pancreatitis-vs-NoPancreatitis
7.184200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.990000E-01
Normal-vs-N1
8.796000E-01
N0-vs-N1
7.669200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.186000E-01
Normal-vs-TP53-NonMutant
9.647400E-01
TP53-Mutant-vs-TP53-NonMutant
7.855200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
